GlassScriptPhysician profile
Andrew Pittner
NPI 1770932741
$5,263.57
in general payments reported to CMS, 2019-2025
23 companies · $1,238 in 2025
The $1,238 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $254 · 2021: $31.00 · 2022: $369 · 2023: $747 · 2024: $2,522 · 2025: $1,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,080 · Consulting Fee: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,079.80 |
| Consulting Fee | $1,428.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $1,534.77 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $905.72 | 2019-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Abbvie INC. | $828.81 | 2022-2025 | |
| New World Medical,INC. | $430.14 | 2021-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Streamline |
| Mallinckrodt Hospital Products INC. | $216.90 | 2023-2025 | Acthar |
| Bausch & Lomb Americas INC. | $207.07 | 2023-2025 | Envista Envy, Miebo, Xiidra |
| Sight Sciences, INC. | $200.87 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Rayner Intraocular Lenses Limited | $147.26 | 2023-2025 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Harrow Eye, LLC | $123.62 | 2024-2025 | Vevye |
| Amgen INC. | $123.18 | 2025 | Tepezza |
| Biotissue Holdings INC. | $102.89 | 2023-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $82.23 | 2020 | |
| Thea Pharma INC. | $71.20 | 2025 | Iyuzeh |
| Sun Pharmaceutical Industries INC. | $69.10 | 2023-2024 | Cequa |
| Iridex Corporation | $41.06 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $35.62 | 2022-2023 | |
| Horizon Therapeutics Plc | $26.56 | 2023 | Uplizna |
| Glaukos Corporation | $24.50 | 2024 | Radius |
| Dompe US, INC. | $21.63 | 2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $18.80 | 2022 | |
| Oyster Point Pharma, INC. | $18.00 | 2022 | |
| Rxsight INC | $17.23 | 2025 | Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| The Cameron-Ehlen Group, INC. | $16.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Pittner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.